IBDEI309 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47993,0)
;;=I73.00^^185^2414^75
;;^UTILITY(U,$J,358.3,47993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47993,1,3,0)
;;=3^Raynaud's Syndrome w/o Gangrene
;;^UTILITY(U,$J,358.3,47993,1,4,0)
;;=4^I73.00
;;^UTILITY(U,$J,358.3,47993,2)
;;=^5007796
;;^UTILITY(U,$J,358.3,47994,0)
;;=R57.0^^185^2414^76
;;^UTILITY(U,$J,358.3,47994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47994,1,3,0)
;;=3^Shock,Cardiogenic
;;^UTILITY(U,$J,358.3,47994,1,4,0)
;;=4^R57.0
;;^UTILITY(U,$J,358.3,47994,2)
;;=^5019525
;;^UTILITY(U,$J,358.3,47995,0)
;;=R57.1^^185^2414^77
;;^UTILITY(U,$J,358.3,47995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47995,1,3,0)
;;=3^Shock,Hypovolemic
;;^UTILITY(U,$J,358.3,47995,1,4,0)
;;=4^R57.1
;;^UTILITY(U,$J,358.3,47995,2)
;;=^60845
;;^UTILITY(U,$J,358.3,47996,0)
;;=R57.9^^185^2414^78
;;^UTILITY(U,$J,358.3,47996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47996,1,3,0)
;;=3^Shock,Unspec
;;^UTILITY(U,$J,358.3,47996,1,4,0)
;;=4^R57.9
;;^UTILITY(U,$J,358.3,47996,2)
;;=^5019527
;;^UTILITY(U,$J,358.3,47997,0)
;;=R55.^^185^2414^79
;;^UTILITY(U,$J,358.3,47997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47997,1,3,0)
;;=3^Syncope and Collapse
;;^UTILITY(U,$J,358.3,47997,1,4,0)
;;=4^R55.
;;^UTILITY(U,$J,358.3,47997,2)
;;=^116707
;;^UTILITY(U,$J,358.3,47998,0)
;;=I78.0^^185^2414^80
;;^UTILITY(U,$J,358.3,47998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47998,1,3,0)
;;=3^Telangiectasia,Hereditary Hemorrhagic
;;^UTILITY(U,$J,358.3,47998,1,4,0)
;;=4^I78.0
;;^UTILITY(U,$J,358.3,47998,2)
;;=^117566
;;^UTILITY(U,$J,358.3,47999,0)
;;=I73.1^^185^2414^20
;;^UTILITY(U,$J,358.3,47999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47999,1,3,0)
;;=3^Buerger's Disease
;;^UTILITY(U,$J,358.3,47999,1,4,0)
;;=4^I73.1
;;^UTILITY(U,$J,358.3,47999,2)
;;=^5007798
;;^UTILITY(U,$J,358.3,48000,0)
;;=G45.9^^185^2414^81
;;^UTILITY(U,$J,358.3,48000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48000,1,3,0)
;;=3^Transient Cerebral Ischemic Attack,Unspec
;;^UTILITY(U,$J,358.3,48000,1,4,0)
;;=4^G45.9
;;^UTILITY(U,$J,358.3,48000,2)
;;=^5003959
;;^UTILITY(U,$J,358.3,48001,0)
;;=G45.8^^185^2414^82
;;^UTILITY(U,$J,358.3,48001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48001,1,3,0)
;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
;;^UTILITY(U,$J,358.3,48001,1,4,0)
;;=4^G45.8
;;^UTILITY(U,$J,358.3,48001,2)
;;=^5003958
;;^UTILITY(U,$J,358.3,48002,0)
;;=I83.019^^185^2414^85
;;^UTILITY(U,$J,358.3,48002,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48002,1,3,0)
;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
;;^UTILITY(U,$J,358.3,48002,1,4,0)
;;=4^I83.019
;;^UTILITY(U,$J,358.3,48002,2)
;;=^5007979
;;^UTILITY(U,$J,358.3,48003,0)
;;=I83.899^^185^2414^83
;;^UTILITY(U,$J,358.3,48003,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48003,1,3,0)
;;=3^Varicose Veins Lower Extrem w/ Other Complications
;;^UTILITY(U,$J,358.3,48003,1,4,0)
;;=4^I83.899
;;^UTILITY(U,$J,358.3,48003,2)
;;=^5008018
;;^UTILITY(U,$J,358.3,48004,0)
;;=I83.90^^185^2414^84
;;^UTILITY(U,$J,358.3,48004,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48004,1,3,0)
;;=3^Varicose Veins Lower Extrem,Asymptomatic
;;^UTILITY(U,$J,358.3,48004,1,4,0)
;;=4^I83.90
;;^UTILITY(U,$J,358.3,48004,2)
;;=^5008019
;;^UTILITY(U,$J,358.3,48005,0)
;;=I87.2^^185^2414^86
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI309 3746 printed Apr 09, 2024@21:36:43 Page 2
IBDEI309 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47993,0)
+2 ;;=I73.00^^185^2414^75
+3 ;;^UTILITY(U,$J,358.3,47993,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,47993,1,3,0)
+6 ;;=3^Raynaud's Syndrome w/o Gangrene
+7 ;;^UTILITY(U,$J,358.3,47993,1,4,0)
+8 ;;=4^I73.00
+9 ;;^UTILITY(U,$J,358.3,47993,2)
+10 ;;=^5007796
+11 ;;^UTILITY(U,$J,358.3,47994,0)
+12 ;;=R57.0^^185^2414^76
+13 ;;^UTILITY(U,$J,358.3,47994,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,47994,1,3,0)
+16 ;;=3^Shock,Cardiogenic
+17 ;;^UTILITY(U,$J,358.3,47994,1,4,0)
+18 ;;=4^R57.0
+19 ;;^UTILITY(U,$J,358.3,47994,2)
+20 ;;=^5019525
+21 ;;^UTILITY(U,$J,358.3,47995,0)
+22 ;;=R57.1^^185^2414^77
+23 ;;^UTILITY(U,$J,358.3,47995,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,47995,1,3,0)
+26 ;;=3^Shock,Hypovolemic
+27 ;;^UTILITY(U,$J,358.3,47995,1,4,0)
+28 ;;=4^R57.1
+29 ;;^UTILITY(U,$J,358.3,47995,2)
+30 ;;=^60845
+31 ;;^UTILITY(U,$J,358.3,47996,0)
+32 ;;=R57.9^^185^2414^78
+33 ;;^UTILITY(U,$J,358.3,47996,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,47996,1,3,0)
+36 ;;=3^Shock,Unspec
+37 ;;^UTILITY(U,$J,358.3,47996,1,4,0)
+38 ;;=4^R57.9
+39 ;;^UTILITY(U,$J,358.3,47996,2)
+40 ;;=^5019527
+41 ;;^UTILITY(U,$J,358.3,47997,0)
+42 ;;=R55.^^185^2414^79
+43 ;;^UTILITY(U,$J,358.3,47997,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,47997,1,3,0)
+46 ;;=3^Syncope and Collapse
+47 ;;^UTILITY(U,$J,358.3,47997,1,4,0)
+48 ;;=4^R55.
+49 ;;^UTILITY(U,$J,358.3,47997,2)
+50 ;;=^116707
+51 ;;^UTILITY(U,$J,358.3,47998,0)
+52 ;;=I78.0^^185^2414^80
+53 ;;^UTILITY(U,$J,358.3,47998,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,47998,1,3,0)
+56 ;;=3^Telangiectasia,Hereditary Hemorrhagic
+57 ;;^UTILITY(U,$J,358.3,47998,1,4,0)
+58 ;;=4^I78.0
+59 ;;^UTILITY(U,$J,358.3,47998,2)
+60 ;;=^117566
+61 ;;^UTILITY(U,$J,358.3,47999,0)
+62 ;;=I73.1^^185^2414^20
+63 ;;^UTILITY(U,$J,358.3,47999,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,47999,1,3,0)
+66 ;;=3^Buerger's Disease
+67 ;;^UTILITY(U,$J,358.3,47999,1,4,0)
+68 ;;=4^I73.1
+69 ;;^UTILITY(U,$J,358.3,47999,2)
+70 ;;=^5007798
+71 ;;^UTILITY(U,$J,358.3,48000,0)
+72 ;;=G45.9^^185^2414^81
+73 ;;^UTILITY(U,$J,358.3,48000,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,48000,1,3,0)
+76 ;;=3^Transient Cerebral Ischemic Attack,Unspec
+77 ;;^UTILITY(U,$J,358.3,48000,1,4,0)
+78 ;;=4^G45.9
+79 ;;^UTILITY(U,$J,358.3,48000,2)
+80 ;;=^5003959
+81 ;;^UTILITY(U,$J,358.3,48001,0)
+82 ;;=G45.8^^185^2414^82
+83 ;;^UTILITY(U,$J,358.3,48001,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,48001,1,3,0)
+86 ;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
+87 ;;^UTILITY(U,$J,358.3,48001,1,4,0)
+88 ;;=4^G45.8
+89 ;;^UTILITY(U,$J,358.3,48001,2)
+90 ;;=^5003958
+91 ;;^UTILITY(U,$J,358.3,48002,0)
+92 ;;=I83.019^^185^2414^85
+93 ;;^UTILITY(U,$J,358.3,48002,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,48002,1,3,0)
+96 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
+97 ;;^UTILITY(U,$J,358.3,48002,1,4,0)
+98 ;;=4^I83.019
+99 ;;^UTILITY(U,$J,358.3,48002,2)
+100 ;;=^5007979
+101 ;;^UTILITY(U,$J,358.3,48003,0)
+102 ;;=I83.899^^185^2414^83
+103 ;;^UTILITY(U,$J,358.3,48003,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,48003,1,3,0)
+106 ;;=3^Varicose Veins Lower Extrem w/ Other Complications
+107 ;;^UTILITY(U,$J,358.3,48003,1,4,0)
+108 ;;=4^I83.899
+109 ;;^UTILITY(U,$J,358.3,48003,2)
+110 ;;=^5008018
+111 ;;^UTILITY(U,$J,358.3,48004,0)
+112 ;;=I83.90^^185^2414^84
+113 ;;^UTILITY(U,$J,358.3,48004,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,48004,1,3,0)
+116 ;;=3^Varicose Veins Lower Extrem,Asymptomatic
+117 ;;^UTILITY(U,$J,358.3,48004,1,4,0)
+118 ;;=4^I83.90
+119 ;;^UTILITY(U,$J,358.3,48004,2)
+120 ;;=^5008019
+121 ;;^UTILITY(U,$J,358.3,48005,0)
+122 ;;=I87.2^^185^2414^86
